Global NSCLS Drugs Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15134111 | Publishing Date : 28-Jan-2020 | No. of pages : 125
Detailed TOC of Global NSCLS Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NSCLS Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global NSCLS Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 EGFR Targeting
1.4.3 ALK Targeting
1.4.4 PD-1/PD-L1 Targeting
1.4.5 Gemcitabine
1.4.6 Cisplatin/Carboplatin
1.4.7 Pemetrexed
1.4.8 Paclitaxel
1.4.9 Others
1.5 Market by Application
1.5.1 Global NSCLS Drugs Market Share by Application: 2020 VS 2026
1.5.2 ≤ 30 Years Old
1.5.3 31 - 45 Years Old
1.5.4 46 - 60 Years Old
1.5.5 > 60 Years Old
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 NSCLS Drugs Market Perspective (2015-2026)
2.2 NSCLS Drugs Growth Trends by Regions
2.2.1 NSCLS Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 NSCLS Drugs Historic Market Share by Regions (2015-2020)
2.2.3 NSCLS Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 NSCLS Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key NSCLS Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top NSCLS Drugs Players by Market Size
3.1.1 Global Top NSCLS Drugs Players by Revenue (2015-2020)
3.1.2 Global NSCLS Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global NSCLS Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global NSCLS Drugs Market Concentration Ratio
3.2.1 Global NSCLS Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by NSCLS Drugs Revenue in 2019
3.3 NSCLS Drugs Key Players Head office and Area Served
3.4 Key Players NSCLS Drugs Product Solution and Service
3.5 Date of Enter into NSCLS Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global NSCLS Drugs Historic Market Size by Type (2015-2020)
4.2 Global NSCLS Drugs Forecasted Market Size by Type (2021-2026)
5 NSCLS Drugs Breakdown Data by Application (2015-2026)
5.1 Global NSCLS Drugs Market Size by Application (2015-2020)
5.2 Global NSCLS Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America NSCLS Drugs Market Size (2015-2020)
6.2 NSCLS Drugs Key Players in North America (2019-2020)
6.3 North America NSCLS Drugs Market Size by Type (2015-2020)
6.4 North America NSCLS Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe NSCLS Drugs Market Size (2015-2020)
7.2 NSCLS Drugs Key Players in Europe (2019-2020)
7.3 Europe NSCLS Drugs Market Size by Type (2015-2020)
7.4 Europe NSCLS Drugs Market Size by Application (2015-2020)
8 China
8.1 China NSCLS Drugs Market Size (2015-2020)
8.2 NSCLS Drugs Key Players in China (2019-2020)
8.3 China NSCLS Drugs Market Size by Type (2015-2020)
8.4 China NSCLS Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan NSCLS Drugs Market Size (2015-2020)
9.2 NSCLS Drugs Key Players in Japan (2019-2020)
9.3 Japan NSCLS Drugs Market Size by Type (2015-2020)
9.4 Japan NSCLS Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia NSCLS Drugs Market Size (2015-2020)
10.2 NSCLS Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia NSCLS Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia NSCLS Drugs Market Size by Application (2015-2020)
11 India
11.1 India NSCLS Drugs Market Size (2015-2020)
11.2 NSCLS Drugs Key Players in India (2019-2020)
11.3 India NSCLS Drugs Market Size by Type (2015-2020)
11.4 India NSCLS Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America NSCLS Drugs Market Size (2015-2020)
12.2 NSCLS Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America NSCLS Drugs Market Size by Type (2015-2020)
12.4 Central & South America NSCLS Drugs Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview and Its Total Revenue
13.1.3 Roche NSCLS Drugs Introduction
13.1.4 Roche Revenue in NSCLS Drugs Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis NSCLS Drugs Introduction
13.2.4 Novartis Revenue in NSCLS Drugs Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview and Its Total Revenue
13.3.3 Pfizer NSCLS Drugs Introduction
13.3.4 Pfizer Revenue in NSCLS Drugs Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview and Its Total Revenue
13.4.3 Merck NSCLS Drugs Introduction
13.4.4 Merck Revenue in NSCLS Drugs Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Details
13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.5.3 Bristol-Myers Squibb NSCLS Drugs Introduction
13.5.4 Bristol-Myers Squibb Revenue in NSCLS Drugs Business (2015-2020)
13.5.5 Bristol-Myers Squibb Recent Development
13.6 Eli Lilly and Company
13.6.1 Eli Lilly and Company Company Details
13.6.2 Eli Lilly and Company Business Overview and Its Total Revenue
13.6.3 Eli Lilly and Company NSCLS Drugs Introduction
13.6.4 Eli Lilly and Company Revenue in NSCLS Drugs Business (2015-2020)
13.6.5 Eli Lilly and Company Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
13.7.3 Takeda Pharmaceutical NSCLS Drugs Introduction
13.7.4 Takeda Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
13.8 Boehringer-Ingelheim
13.8.1 Boehringer-Ingelheim Company Details
13.8.2 Boehringer-Ingelheim Business Overview and Its Total Revenue
13.8.3 Boehringer-Ingelheim NSCLS Drugs Introduction
13.8.4 Boehringer-Ingelheim Revenue in NSCLS Drugs Business (2015-2020)
13.8.5 Boehringer-Ingelheim Recent Development
13.9 AstraZeneca
13.9.1 AstraZeneca Company Details
13.9.2 AstraZeneca Business Overview and Its Total Revenue
13.9.3 AstraZeneca NSCLS Drugs Introduction
13.9.4 AstraZeneca Revenue in NSCLS Drugs Business (2015-2020)
13.9.5 AstraZeneca Recent Development
13.10 Betta Pharmaceuticals
13.10.1 Betta Pharmaceuticals Company Details
13.10.2 Betta Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Betta Pharmaceuticals NSCLS Drugs Introduction
13.10.4 Betta Pharmaceuticals Revenue in NSCLS Drugs Business (2015-2020)
13.10.5 Betta Pharmaceuticals Recent Development
13.11 Qilu Oharmaceutical
10.11.1 Qilu Oharmaceutical Company Details
10.11.2 Qilu Oharmaceutical Business Overview and Its Total Revenue
10.11.3 Qilu Oharmaceutical NSCLS Drugs Introduction
10.11.4 Qilu Oharmaceutical Revenue in NSCLS Drugs Business (2015-2020)
10.11.5 Qilu Oharmaceutical Recent Development
13.12 Pierre Fabre Medicament
10.12.1 Pierre Fabre Medicament Company Details
10.12.2 Pierre Fabre Medicament Business Overview and Its Total Revenue
10.12.3 Pierre Fabre Medicament NSCLS Drugs Introduction
10.12.4 Pierre Fabre Medicament Revenue in NSCLS Drugs Business (2015-2020)
10.12.5 Pierre Fabre Medicament Recent Development
13.13 Chemo Wanbang Biopharma
10.13.1 Chemo Wanbang Biopharma Company Details
10.13.2 Chemo Wanbang Biopharma Business Overview and Its Total Revenue
10.13.3 Chemo Wanbang Biopharma NSCLS Drugs Introduction
10.13.4 Chemo Wanbang Biopharma Revenue in NSCLS Drugs Business (2015-2020)
10.13.5 Chemo Wanbang Biopharma Recent Development
13.14 Hetero Drugs
10.14.1 Hetero Drugs Company Details
10.14.2 Hetero Drugs Business Overview and Its Total Revenue
10.14.3 Hetero Drugs NSCLS Drugs Introduction
10.14.4 Hetero Drugs Revenue in NSCLS Drugs Business (2015-2020)
10.14.5 Hetero Drugs Recent Development
13.15 Harbin Gloria Pharmaceuticals
10.15.1 Harbin Gloria Pharmaceuticals Company Details
10.15.2 Harbin Gloria Pharmaceuticals Business Overview and Its Total Revenue
10.15.3 Harbin Gloria Pharmaceuticals NSCLS Drugs Introduction
10.15.4 Harbin Gloria Pharmaceuticals Revenue in NSCLS Drugs Business (2015-2020)
10.15.5 Harbin Gloria Pharmaceuticals Recent Development
13.16 Luoxin Pharmaceutical
10.16.1 Luoxin Pharmaceutical Company Details
10.16.2 Luoxin Pharmaceutical Business Overview and Its Total Revenue
10.16.3 Luoxin Pharmaceutical NSCLS Drugs Introduction
10.16.4 Luoxin Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020)
10.16.5 Luoxin Pharmaceutical Recent Development
13.17 Teva Pharmaceutical
10.17.1 Teva Pharmaceutical Company Details
10.17.2 Teva Pharmaceutical Business Overview and Its Total Revenue
10.17.3 Teva Pharmaceutical NSCLS Drugs Introduction
10.17.4 Teva Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020)
10.17.5 Teva Pharmaceutical Recent Development
13.18 Mylan
10.18.1 Mylan Company Details
10.18.2 Mylan Business Overview and Its Total Revenue
10.18.3 Mylan NSCLS Drugs Introduction
10.18.4 Mylan Revenue in NSCLS Drugs Business (2015-2020)
10.18.5 Mylan Recent Development
13.19 Sun Pharmaceutical
10.19.1 Sun Pharmaceutical Company Details
10.19.2 Sun Pharmaceutical Business Overview and Its Total Revenue
10.19.3 Sun Pharmaceutical NSCLS Drugs Introduction
10.19.4 Sun Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020)
10.19.5 Sun Pharmaceutical Recent Development
13.20 Fosun Pharma
10.20.1 Fosun Pharma Company Details
10.20.2 Fosun Pharma Business Overview and Its Total Revenue
10.20.3 Fosun Pharma NSCLS Drugs Introduction
10.20.4 Fosun Pharma Revenue in NSCLS Drugs Business (2015-2020)
10.20.5 Fosun Pharma Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global NSCLS Drugs Market Size, Status and Forecast 2020-2026
List of TablesTable 1. NSCLS Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by NSCLS Drugs Revenue
Table 3. Ranking of Global Top NSCLS Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global NSCLS Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of EGFR Targeting
Table 6. Key Players of ALK Targeting
Table 7. Key Players of PD-1/PD-L1 Targeting
Table 8. Key Players of Gemcitabine
Table 9. Key Players of Cisplatin/Carboplatin
Table 10. Key Players of Pemetrexed
Table 11. Key Players of Paclitaxel
Table 12. Key Players of Others
Table 13. Global NSCLS Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global NSCLS Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global NSCLS Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global NSCLS Drugs Market Share by Regions (2015-2020)
Table 17. Global NSCLS Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global NSCLS Drugs Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. NSCLS Drugs Market Growth Strategy
Table 23. Main Points Interviewed from Key NSCLS Drugs Players
Table 24. Global NSCLS Drugs Revenue by Players (2015-2020) (Million US$)
Table 25. Global NSCLS Drugs Market Share by Players (2015-2020)
Table 26. Global Top NSCLS Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSCLS Drugs as of 2019)
Table 27. Global NSCLS Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players NSCLS Drugs Product Solution and Service
Table 30. Date of Enter into NSCLS Drugs Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 33. Global NSCLS Drugs Market Size Share by Type (2015-2020)
Table 34. Global NSCLS Drugs Revenue Market Share by Type (2021-2026)
Table 35. Global NSCLS Drugs Market Size Share by Application (2015-2020)
Table 36. Global NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. Global NSCLS Drugs Market Size Share by Application (2021-2026)
Table 38. North America Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 39. North America Key Players NSCLS Drugs Market Share (2019-2020)
Table 40. North America NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. North America NSCLS Drugs Market Share by Type (2015-2020)
Table 42. North America NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. North America NSCLS Drugs Market Share by Application (2015-2020)
Table 44. Europe Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players NSCLS Drugs Market Share (2019-2020)
Table 46. Europe NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. Europe NSCLS Drugs Market Share by Type (2015-2020)
Table 48. Europe NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. Europe NSCLS Drugs Market Share by Application (2015-2020)
Table 50. China Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 51. China Key Players NSCLS Drugs Market Share (2019-2020)
Table 52. China NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. China NSCLS Drugs Market Share by Type (2015-2020)
Table 54. China NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. China NSCLS Drugs Market Share by Application (2015-2020)
Table 56. Japan Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players NSCLS Drugs Market Share (2019-2020)
Table 58. Japan NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Japan NSCLS Drugs Market Share by Type (2015-2020)
Table 60. Japan NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Japan NSCLS Drugs Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players NSCLS Drugs Market Share (2019-2020)
Table 64. Southeast Asia NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia NSCLS Drugs Market Share by Type (2015-2020)
Table 66. Southeast Asia NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia NSCLS Drugs Market Share by Application (2015-2020)
Table 68. India Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 69. India Key Players NSCLS Drugs Market Share (2019-2020)
Table 70. India NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. India NSCLS Drugs Market Share by Type (2015-2020)
Table 72. India NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. India NSCLS Drugs Market Share by Application (2015-2020)
Table 74. Central & South America Key Players NSCLS Drugs Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players NSCLS Drugs Market Share (2019-2020)
Table 76. Central & South America NSCLS Drugs Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America NSCLS Drugs Market Share by Type (2015-2020)
Table 78. Central & South America NSCLS Drugs Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America NSCLS Drugs Market Share by Application (2015-2020)
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Product
Table 83. Roche Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 84. Roche Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Merck Company Details
Table 96. Merck Business Overview
Table 97. Merck Product
Table 98. Merck Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 99. Merck Recent Development
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Eli Lilly and Company Company Details
Table 106. Eli Lilly and Company Business Overview
Table 107. Eli Lilly and Company Product
Table 108. Eli Lilly and Company Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 109. Eli Lilly and Company Recent Development
Table 110. Takeda Pharmaceutical Company Details
Table 111. Takeda Pharmaceutical Business Overview
Table 112. Takeda Pharmaceutical Product
Table 113. Takeda Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 114. Takeda Pharmaceutical Recent Development
Table 115. Boehringer-Ingelheim Business Overview
Table 116. Boehringer-Ingelheim Product
Table 117. Boehringer-Ingelheim Company Details
Table 118. Boehringer-Ingelheim Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 119. Boehringer-Ingelheim Recent Development
Table 120. AstraZeneca Company Details
Table 121. AstraZeneca Business Overview
Table 122. AstraZeneca Product
Table 123. AstraZeneca Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 124. AstraZeneca Recent Development
Table 125. Betta Pharmaceuticals Company Details
Table 126. Betta Pharmaceuticals Business Overview
Table 127. Betta Pharmaceuticals Product
Table 128. Betta Pharmaceuticals Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 129. Betta Pharmaceuticals Recent Development
Table 130. Qilu Oharmaceutical Company Details
Table 131. Qilu Oharmaceutical Business Overview
Table 132. Qilu Oharmaceutical Product
Table 133. Qilu Oharmaceutical Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 134. Qilu Oharmaceutical Recent Development
Table 135. Pierre Fabre Medicament Company Details
Table 136. Pierre Fabre Medicament Business Overview
Table 137. Pierre Fabre Medicament Product
Table 138. Pierre Fabre Medicament Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 139. Pierre Fabre Medicament Recent Development
Table 140. Chemo Wanbang Biopharma Company Details
Table 141. Chemo Wanbang Biopharma Business Overview
Table 142. Chemo Wanbang Biopharma Product
Table 143. Chemo Wanbang Biopharma Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 144. Chemo Wanbang Biopharma Recent Development
Table 145. Hetero Drugs Company Details
Table 146. Hetero Drugs Business Overview
Table 147. Hetero Drugs Product
Table 148. Hetero Drugs Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 149. Hetero Drugs Recent Development
Table 150. Harbin Gloria Pharmaceuticals Company Details
Table 151. Harbin Gloria Pharmaceuticals Business Overview
Table 152. Harbin Gloria Pharmaceuticals Product
Table 153. Harbin Gloria Pharmaceuticals Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 154. Harbin Gloria Pharmaceuticals Recent Development
Table 155. Luoxin Pharmaceutical Company Details
Table 156. Luoxin Pharmaceutical Business Overview
Table 157. Luoxin Pharmaceutical Product
Table 158. Luoxin Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 159. Luoxin Pharmaceutical Recent Development
Table 160. Teva Pharmaceutical Company Details
Table 161. Teva Pharmaceutical Business Overview
Table 162. Teva Pharmaceutical Product
Table 163. Teva Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 164. Teva Pharmaceutical Recent Development
Table 165. Mylan Company Details
Table 166. Mylan Business Overview
Table 167. Mylan Product
Table 168. Mylan Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 169. Mylan Recent Development
Table 170. Sun Pharmaceutical Company Details
Table 171. Sun Pharmaceutical Business Overview
Table 172. Sun Pharmaceutical Product
Table 173. Sun Pharmaceutical Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 174. Sun Pharmaceutical Recent Development
Table 175. Fosun Pharma Company Details
Table 176. Fosun Pharma Business Overview
Table 177. Fosun Pharma Product
Table 178. Fosun Pharma Revenue in NSCLS Drugs Business (2015-2020) (Million US$)
Table 179. Fosun Pharma Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSCLS Drugs Market Share by Type: 2020 VS 2026
Figure 2. EGFR Targeting Features
Figure 3. ALK Targeting Features
Figure 4. PD-1/PD-L1 Targeting Features
Figure 5. Gemcitabine Features
Figure 6. Cisplatin/Carboplatin Features
Figure 7. Pemetrexed Features
Figure 8. Paclitaxel Features
Figure 9. Others Features
Figure 10. Global NSCLS Drugs Market Share by Application: 2020 VS 2026
Figure 11. ≤ 30 Years Old Case Studies
Figure 12. 31 - 45 Years Old Case Studies
Figure 13. 46 - 60 Years Old Case Studies
Figure 14. > 60 Years Old Case Studies
Figure 15. NSCLS Drugs Report Years Considered
Figure 16. Global NSCLS Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global NSCLS Drugs Market Share by Regions: 2020 VS 2026
Figure 18. Global NSCLS Drugs Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global NSCLS Drugs Market Share by Players in 2019
Figure 21. Global Top NSCLS Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSCLS Drugs as of 2019
Figure 22. The Top 10 and 5 Players Market Share by NSCLS Drugs Revenue in 2019
Figure 23. North America NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America NSCLS Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Roche Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 32. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Novartis Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 36. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Merck Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 38. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bristol-Myers Squibb Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 40. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eli Lilly and Company Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 42. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Takeda Pharmaceutical Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 44. Boehringer-Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Boehringer-Ingelheim Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. AstraZeneca Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 48. Betta Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Betta Pharmaceuticals Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 50. Qilu Oharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Qilu Oharmaceutical Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 52. Pierre Fabre Medicament Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pierre Fabre Medicament Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 54. Chemo Wanbang Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Chemo Wanbang Biopharma Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 56. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Hetero Drugs Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 58. Harbin Gloria Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Harbin Gloria Pharmaceuticals Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 60. Luoxin Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Luoxin Pharmaceutical Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 62. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Teva Pharmaceutical Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 64. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Mylan Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 66. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Sun Pharmaceutical Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 68. Fosun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Fosun Pharma Revenue Growth Rate in NSCLS Drugs Business (2015-2020)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Keyplayers in Global NSCLS Drugs Market Size, Status and Forecast 2020-2026
RocheNovartis
Pfizer
Merck
Bristol-Myers Squibb
Eli Lilly and Company
Takeda Pharmaceutical
Boehringer-Ingelheim
AstraZeneca
Betta Pharmaceuticals
Qilu Oharmaceutical
Pierre Fabre Medicament
Chemo Wanbang Biopharma
Hetero Drugs
Harbin Gloria Pharmaceuticals
Luoxin Pharmaceutical
Teva Pharmaceutical
Mylan
Sun Pharmaceutical
Fosun Pharma